The loss of NRK expression in tissues may hinder the effectiveness of supplementing NAD+ precursors to raise NAD+ levels, while NT5E provides NR as the conversion substrate for NRK, underscoring the critical roles of NRK and NT5E in NAD+ supplementation therapy for HF. Here, NRK is linked to hydrops fetalis.